Search filters

List of works by Henry Marsh

337 Expansion of Dendritic Cells Using FLT3 Ligand to Treat Glioblastoma: A Preclinical Study

scientific article published in August 2016

A Critical Role of CD40 and CD70 Signaling in Conventional Type 1 Dendritic Cells in Expansion and Antitumor Efficacy of Adoptively Transferred Tumor-Specific T Cells

scientific article published on 26 August 2020

A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway

scientific article published on 01 August 1996

Activation of the spinal cord complement cascade might contribute to mechanical allodynia induced by three animal models of spinal sensitization

scientific article published on 01 March 2005

Agonist anti-human CD27 monoclonal antibody induces T cell activation and tumor immunity in human CD27-transgenic mice

scientific article

Beneficial effects of complement inhibition with soluble complement receptor 1 (TP10) during cardiac surgery: is there a gender difference?

scientific article

CD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor Efficacy.

scientific article published on 6 November 2017

Characterization of monoclonal antibodies specific for the V beta 3 family of the human T cell receptor generated using soluble TCR beta-chain.

scientific article published on September 1993

Characterization of the human T cell response to in vitro CD27 costimulation with varlilumab

scientific article

Comparison of complement activity in adult and preterm sheep serum

scientific article published on 21 July 2014

Complement activation as a cause for primary graft failure in an isogeneic rat model of hypothermic lung preservation and transplantation ⬇️

scientific article published on November 15, 1997

Design, synthesis, and evaluation of A/C/D-ring analogs of the fungal metabolite K-76 as potential complement inhibitors.

scientific article published in April 1995

Development of a Novel Antibody-Drug Conjugate for the Potential Treatment of Ovarian, Lung, and Renal Cell Carcinoma Expressing TIM-1.

scientific article published on 26 September 2016

Effect of continuous complement inhibition using soluble complement receptor type 1 on survival of pig-to-primate cardiac xenografts

scientific article published on 01 March 1997

Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival

scientific article published on 01 August 1996

Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers

scientific article

FLT3L and plerixafor combination increases hematopoietic stem cell mobilization and leads to improved transplantation outcome.

scientific article published on 21 December 2013

Mapping epitopes for 20 monoclonal antibodies to CR1 ⬇️

scientific article published on April 1, 1998

Mechanism of action of thrombin on fibrinogen. Direct evidence for the involvement of phenylalanine at position P9

scientific article published on 01 November 1982

Mechanism of action of thrombin on fibrinogen. Kinetic evidence for involvement of aspartic acid at position P10

scientific article published on 01 August 1983

Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s

scientific article published on 27 October 2020

Peri-sciatic proinflammatory cytokines, reactive oxygen species, and complement induce mirror-image neuropathic pain in rats

scientific article published on 01 July 2004

Pre-clinical evaluation of an sLe x-glycosylated complement inhibitory protein in a non-human primate model of reperfused stroke

scientific article published on 01 December 2007

Reduction of myocardial infarct size with sCR1sLe(x), an alternatively glycosylated form of human soluble complement receptor type 1 (sCR1), possessing sialyl Lewis x.

scientific article published on November 1999

Soluble human complement receptor 1 limits ischemic damage in cardiac surgery patients at high risk requiring cardiopulmonary bypass.

scientific article

Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis

scientific article

Synthesis and complement inhibitory activity of B/C/D-ring analogues of the fungal metabolite 6,7-diformyl-3',4',4a',5',6',7',8',8a'-octahydro-4,6',7'-trihydroxy- 2',5',5',8a'-tetramethylspiro[1'(2'H)-naphthalene-2(3H)-benzofuran]

scientific article published on 01 June 2003

Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination

scientific article published on 08 April 2019

Targeting human CD27 with an agonist antibody stimulates T-cell activation and antitumor immunity

scientific article published on January 2014

The nature of the slow metal ion-dependent conformational transition in bovine prothrombin ⬇️

scientific article published on December 1, 1979

The partly folded back solution structure arrangement of the 30 SCR domains in human complement receptor type 1 (CR1) permits access to its C3b and C4b ligands

scientific article

Toll-like receptor agonists shape the immune responses to a mannose receptor-targeted cancer vaccine

scientific article published on 27 October 2014

Total complement inhibition: an effective strategy to limit ischemic injury during coronary revascularization on cardiopulmonary bypass

scientific article published on 01 September 1999

Tryptophan exposure in various conformational isomers of bovine prothrombin fragment 1. An acrylamide quenching study

scientific article published on 01 January 1981

Two distinct immunogenic epitopes on the alpha chain of human T cell antigen receptor

scientific article published on 01 December 1989

Ultrathin coating by plasma polymerization applied to corneal contact lens

scientific article published on 01 November 1975

Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis

scientific article published on 01 September 2000

Paulina is supported by:

About Paulina

Help